Prognostic value of von Willebrand factor levels in patients with metastatic melanoma treated by immune checkpoint inhibitors

Background An increased incidence of thrombotic complications associated with an increased mortality rate has been observed under immune checkpoint inhibition (ICI). Recent investigations on the coagulation pathways have highlighted the direct role of key coagulatory proteins and platelets in cancer...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Stefan W Schneider, Klaus Pantel, Christoffer Gebhardt, Robin Reschke, Christian Mess, Julia-Christina Stadler, Laura Keller, Alexander T Bauer, Julian Koett, Glenn Geidel, Isabel Heidrich, Sabine Vidal-y-Sy, Antje Andreas, Carlotta Stramaglia, Mark Sementsov, Wiebcke Haberstroh, Benjamin Deitert, Inka Lilott Hoehne, Thomas Haalck
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	BMJ Publishing Group 2023-05-01
Serie:	Journal for ImmunoTherapy of Cancer
Accesso online:	https://jitc.bmj.com/content/11/5/e006456.full
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!